SILO PHARMA, INC. Interest Receivable, Current
SILO PHARMA, INC. (SILO) had Interest Receivable, Current of $9.60 thousand as of 2024-06-30, per its 10-Q filed 2024-08-13.
Financial Statements › Notes › and Others
us-gaap:InterestReceivableCurrent · last filed 2025-03-28
- 2024-06-30: Interest Receivable, Current $9.60K.
- 2024-03-31: Interest Receivable, Current $9.60K.
- 2023-12-31: Interest Receivable, Current $9.60K.
- 2023-09-30: Interest Receivable, Current $9.60K.
| Period end | Interest Receivable, Current |
|---|---|
| 2024-06-30 | $9.60K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $9.60K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $9.60K 10-K · filed 2025-03-28 |
| 2023-09-30 | $9.60K 10-Q · filed 2023-11-13 |
| 2022-12-31 | $6.01K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |